1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.
Repligen Corp. XNAS: RGEN

Repligen Corp. Live Stock Price Today, Share Analysis and Chart

Weak Stock
about

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vacc...

Read More
119.85 -1.89 (-1.55%)
34.34% Fall from 52W High
156.8K
XNAS Volume

XNAS 28 Jul, 2025 10:48 AM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Repligen Corp. is on 30 Jul 2025 for the purpose of Repligen Corp Second Quarter Earnings Results for 2025 See details
Durability score
Low Financial Strength
27.8 / 100
Valuation Score
Expensive Valuation
15.2 / 100
Momentum Score
Technically Bearish
29.7 / 100
Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
180
1Yr Price target upside is 50%
18 analysts

5

S

20

W

1

O

2

T

SWOT Analysis

Repligen Corp. Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..